Celestica (CLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Recently, Zacks.com users have been paying close attention to Celestica (CLS). This makes it worthwhile to examine what the stock has in store.
Celestica's revenue rose 21% year-over-year to $9.65B, fueled by CCS growth; FCF jumped 50% amid buybacks and low leverage, indicating strong fundamentals. HPS design capabilities expand margins, forg
- Post-Hoc Analyses Provide Comparative Data on Rescue Criteria and Intervention-Free Rates for Tyrosine Kinase Inhibitors (TKIs) in Wet AMD Development -

New Strong Buy Stocks for March 19th

05:35am, Wednesday, 19'th Mar 2025
CCNE, NATL, CLS, THFF and HTB have been added to the Zacks Rank #1 (Strong Buy) List on March 19, 2025.
Celestica is my top AI Connectivity pick for 2025 due to booming AI business, strong management, and increased hyperscaler capex towards its cloud communication products. Celestica's CCS segment saw m
Recently, Zacks.com users have been paying close attention to Celestica (CLS). This makes it worthwhile to examine what the stock has in store.

Celestica: The Overlooked AI Winner

09:52am, Wednesday, 12'th Mar 2025
Celestica reported Q4-CY24 revenue of $2.55B (+19% YoY), with CCS segment revenue surging 30% YoY to $1.74B. Full-year CY25 revenue is projected at $10.7B (+11% YoY), with adjusted EPS expected to hit
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy

Celestica: A Solid Buying Opportunity

11:59am, Sunday, 09'th Mar 2025
Celestica is rated as a "Strong Buy" due to a 40% stock dip, presenting a golden buying opportunity for GARP investors. Despite tariff concerns, CLS's EPS growth, high operating margins, and strong de
- CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD - - Flexible Dosing and Extended Duration would be Important Differentiators from Existing Approved Therapies and Other Ty

New Strong Buy Stocks for March 6th

05:30am, Thursday, 06'th Mar 2025
TAP, AVBH, CLS, FUNC and HBT have been added to the Zacks Rank #1 (Strong Buy) List on March 6, 2025.

Best Value Stocks to Buy for March 6th

04:40am, Thursday, 06'th Mar 2025
AVBH, CLS and TAP made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 6, 2025.
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Celestica (CLS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CLS broke through the 50-day moving average, which suggests a short-
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE